Lincoln Pharmaceuticals informs about disclosure

07 Jun 2022 Evaluate

Lincoln Pharmaceuticals has informed that the exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ashish Rajanbhai Patel & PACs.

The above information is a part of company’s filings submitted to BSE

Lincoln Pharma Share Price

808.95 -2.75 (-0.34%)
23-Dec-2024 14:25 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1815.85
Dr. Reddys Lab 1335.00
Cipla 1473.25
Lupin 2161.30
Zydus Lifesciences 972.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.